Table 1.
Device | Company | Composition | Mechanism | Substance eliminated |
---|---|---|---|---|
Toraymyxin 20R | Toray Industries, Japan | Polymyxin B covalently bound to polypropylene-polystyrene fibers fabric | Adsorption | Endotoxin |
| ||||
LPS adsorber | Alteco Medical, Sweden | Synthetic polypeptide bound to porous polyethylene discs | Adsorption | Endotoxin |
| ||||
oXiris | Gambro-Hospal, France | AN69-based membrane, surface treated with a polyethyleneimine (PEI) and grafted with heparin | Adsorption Convection |
Endotoxin Cytokines |
| ||||
MATISSE | Fresenius SE, Germany | Human serum albumin immobilised on polymethacrylate beads | Adsorption | Endotoxin |
| ||||
CPFA | Bellco, Italy | Polyethersulfone Plasma filter with adsorption on an unselective hydrophobicresin cartridge, and a synthetic high-permeability polyethersulfone hemofilter for continuous hemofiltration | Adsorption Plasma filtration |
Cytokines |
| ||||
Cytosorb | Cytosorbents, USA | Polystyrenedivinyl benzene copolymer beads with a biocompatible polyvinylpyrrolidone coating. | Adsorption Convection |
Cytokines |